Bayer | chemanager-online.com - Chemistry and Life Science

Sep. 12, 2019
News & Opinions
Bayer Cuts Two Management Board Members
Bayer is reducing its board of management from seven to five members as part of its previously announced cost-cutting measures. Hartmut Klusik and Kemal Malik will leave on Dec. 31, 2019 and their responsibilities will be reallocated.
Sep. 11, 2019
News & Opinions
Bayer Says Monsanto Stakeholder Lists Lawful
Amid the swirling controversy over lists former US agrochemicals giant Monsanto kept on journalists and industry stakeholders, new owner Bayer has said the investigation it commissioned through US law firm Sidley Austin showed that no ...
Sep. 10, 2019
Topics
Continuous Processing
Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how streaming service provider Netflix proposed a partnership to ...
Sep. 09, 2019
Topics
Sustainable Chemical Supply Chains
The Together for Sustainability (TFS) initiative was launched in 2011 as a joint program of chemical companies for sustainable supply chains. Its goal is to develop and implement a global agenda to evaluate and improve sustainable ...
Sep. 06, 2019
News & Opinions
Germany Moves Toward Glyphosate Phase-out
In a compromise agreement presented this week, Germany’s federal cabinet voted to curb the use of the controversial chemical glyphosate up to 2023, active ingredient in the equally controversial herbicide Roundup, and subsequently ...
Aug. 21, 2019
News & Opinions
Bayer to Sell Animal Health to Elanco
As widely expected, Bayer has definitively agreed to sell its animal health business to Eli Lilly spinoff Elanco Animal Health. The $7.6 billion deal will create the market’s second largest player, with a share of 13%, behind Zoetis ...
Aug. 20, 2019
News & Opinions
Syngenta-funded paper Says Glyphosate Best at Dawn
With the debate over the possible carcinogenity of Monsanto’s (now Bayer’s) Roundup herbicide continuing to rage, a peer-reviewed research paper partly funded by Swiss agrochemicals giant Syngenta – now owned by ChemChina ...
Aug. 12, 2019
News & Opinions
Bayer Ready to Wind up Glyphosate Suits?
As the number of lawsuits from people claiming that Monsanto’s Roundup herbicide caused their cancer mount – to currently more than 18,000 –signals increasingly point to an out-of-court settlement.
Aug. 09, 2019
News & Opinions
Bayer Buys Cell Therapy Specialist BlueRock
Bayer has announced it will pay for $240 million upfront to acquire all of BluerockTherapeutics, a privately held US-headquartered biotech in which it currently holds more than 40%. The company will continue to operate independently.
Aug. 07, 2019
News & Opinions
Bayer and Lanxess Divest Currenta Stakes
In separate transactions still subject to approval by regulatory authorities, Bayer and Lanxess have sold their respective 60% and 40% stakes in German infrastructure company Currenta to funds managed by Australia-based Macquarie ...

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag